Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps

Executive Summary

Lilly unveiled a new discount program for its insulins, including Humalog, Humulin and Basaglar, that will reduce costs for people who pay full retail prices.


Related Content

Which Pharma Firm Increases US Prices The Most?
Which Pharma Firm Increases US Prices The Most?
US Insulin Pricing Probe Clouds Prospects for Novo Nordisk, Others
Insulin Pricing, PBM Relationships Under Government Microscope
Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016
Drug Pricing ‘Biggest Offenders’ Are Annual Increases On Widely Used Brands
Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”
Mylan CEO Takes Center Stage To Address EpiPen Pricing Scandal
FDA Makes It Official With Basaglar Approval For Diabetes


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts